Skip to main content

Table 2 A list of collected data regarding adjuvant chemotherapy

From: Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer

Items Category
Treatment regimen  
   - Drug names  
   - Initial dose of each drug (mg/body/day)  
Duration of treatment (days)  
   - Date of starting chemotherapy  
   - Date of finishing chemotherapy  
Reason for finishing chemotherapy Completed the scheduled chemotherapy,
  Discontinued by AEs,
  Discontinued by the other reason,
  Withdrew informed consent
Relative dose intensity ≥75%, 75%>−≥50%, >50%
Most severe grade of each AE (with the date of development)  
   - Hand foot syndrome None, G1, G2, G3
   - Leukocytopenia None, G1-2, G3, G4, G5
   - Neutropenia None, G1-2, G3, G4, G5
   - Diarrhea None, G1-2, G3, G4, G5
   - Vomiting None, G1-2, G3, G4, G5
   - Anorexia/Nausea None, G1-2, G3, G4, G5
   - Increased AST/ALT None, G1-2, G3, G4, G5
   - Hyperbilirubinemia None, G1-2, G3, G4, G5
   - Other AEs* G3, G4, G5
  1. *: To be reported only when the severity is grade 3 or higher.
  2. AE: adverse event.
  3. G: grade (the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0).
  4. AST: aspartate aminotransferase.
  5. ALT: alanine aminotransferase.